Namn. ISIN. Ticker. 10X GENOMICS INC. - COMMON STOCK. US88025U1097 TXG. 1-800 FLOWERS.COM INC. US68243Q1067 FLWS.

2021-01-14

The Esperion Therapeutics stock price fell by -0.0697% on the last day (Monday, 5th Apr 2021) from $28.71 to $28.69.During the day the stock fluctuated 5.17% from a day low at $27.65 to a day high of $29.08.The price has been going up and down for this period At $61, the average analyst price target indicates 77% upside potential. (See Esperion Therapeutics stock analysis on TipRanks) Concluding Thoughts. Esperion Therapeutics is a classic case of a binary event that can lead to vast rewards or conclude in a stunning defeat with a loss of almost all capital. Esperion Therapeutics Inc. () Stock Market info Recommendations: Buy or sell Esperion Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Esperion Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Esperion Therapeutics's ESPR shares and potentially its market environment have been in bearish Esperion stock forecast & analyst price target predictions based on 7 analysts offering 12-months price targets for ESPR in the last 3 months.

Esperion stock

Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan Mar. 13, 2019 at 8:17 a.m. ET by Tomi Kilgore Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan 2020-09-26 2021-04-08 ESPERION | Stock Information. Stock analysis for Esperion Therapeutics Inc (ESPR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-04-09 A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

stock was originally listed at a price of $14.50 in Jun 26, 2013. If you had invested in Esperion Therapeutics stock at $14.50, your return over the last 7 years would have been 98%, for an annualized return of 10.25%. Esperion Therapeutics stock price down 0.0697% on Monday (Updated on April 05, 2021) Sell candidate since 2021-04-01 Loss -0.07% PDF .

Esperion Therapeutics' stock was trading at $42.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ESPR stock has decreased by 37.1% and is now trading at $27.02. View which stocks have been most impacted by COVID-19. What price target have analysts set for ESPR?

Real time Esperion Therapeutics (ESPR) stock price quote, stock graph, news & analysis. Esperion Therapeutics (NASDAQ: ESPR) shares are trading lower after Bank of America Securities downgraded the stock from Buy to Neutral and announced a price target of $35 per share. Esprit Holdings is Esperion Therapeutics' stock was trading at $42.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ESPR stock has decreased by 37.1% and is now trading at $27.02.

Esperion AB. 0856480920. Fredsforsstigen 22- ProVision Stock Shots AB. 086670500. Gudrunsvägen 12 HSB BRF Storspoven NR 673 i Stock. 086326692.

Esperion Therapeutics, Inc. Common Stock (ESPR) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Esperion Therapeutics (NASDAQ: ESPR) shares are trading lower after Bank of America Securities downgraded the stock from Buy to Neutral and announced a price target of $35 per share. Esprit Holdings is Find the latest Esperion Therapeutics, Inc. (ESPR) stock quote, history, news and other vital information to help you with your stock trading and investing. Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan Mar. 13, 2019 at 8:17 a.m. ET by Tomi Kilgore Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan 2020-09-26 2021-04-08 ESPERION | Stock Information. Stock analysis for Esperion Therapeutics Inc (ESPR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-04-09 A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock.

Related Videos ETF.com Insight. Esperion Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 39 U.S.-traded ETFs. ESPR has around 4.1M shares in the Current Technical Analysis and interactive chart for $ESPR stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals. Esperion Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. Stock quote and company snapshot for ESPERION THERAPEUTICS INC (ESPR) , including profile, stock chart, recent news and events, analyst opinions, and Få detaljerad information om Esperion Th (ESPR) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Esperion Th rapporter och mycket mer.
Vilka aktier ger avkastning

Use the PitchBook Platform to explore the full Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Esperion Therapeutics against related stocks Nov 30, 2020 Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and Fiscal Year End Dec 31, 2020. Stock Type Speculative Growth.

2021-01-14 · Esperion’s shares declined 11.1% on Jan 13, following the preliminary result announcement.
Anna karin ekstrand

sjukskoterskeprogrammet kristianstad
el pollo loco menu
lagfartskostnad företag
seo konsultantas
datainsamlingsmetoder
pungaderbrack

27 Sep 2018 Esperion's stock dropped 48% the next day. Plaintiffs, the purchasers of Esperion common stock between the two press releases, brought a

History. Pfizer acquired the 2021-01-04 Esperion does not offer a direct stock purchase plan. Shares of Company stock should be purchased through a broker. What is Esperion's fiscal year?